Trial Details
COMPLETEDBasic Information
| Clinical ID | c1740 |
|---|---|
| Identifier | NCT04186247 |
| Trial Title | Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease|Pediatric Crohns Disease |
| Interventions | DRUG: Azithromycin|DRUG: Metronidazole|OTHER: Standard of Care |
Participant Information
| Sponsor | University of North Carolina, Chapel Hill |
|---|---|
| City | San Francisco |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2021-08-13 |
|---|---|
| Primary Completion Date | 2023-12-31 |
| Completion Date | 2023-12-31 |